Hervé Le Lous

With a PhD from Stanford Business School (California), an MBA from the Wharton School of Finance (Philadelphia) and having graduated in Sciences from the Ecole Normale Supérieure (Paris, 1974), Hervé Le Lous’s background is both scientific and entrepreneurial.

He began his working life as a teacher at ESSEC (Business School) then at the “College des Ingénieurs” (post-graduate) before starting a career in business. In 1987, he bought and turned around a small loss-making company with some of his former students. This small company evolved into what is today the URGO Group, with over 3 100 employees in France and abroad, and 595 million euros turnover in 2017.

Hervé Le Lous is personally involved in teaching and research. He continues to teach at the corporate university he created, the URGO University. He personally believes that “we grow by helping others to grow” and this is why he advises managers to formalise and share their knowledge and experience.

Hervé Le Lous is the Chairman of the URGO Foundation which was created in 2010 to extend the company’s commitment to public health. The Foundation is focusing on three main areas: supporting scientific research, contribution to health education and preventive health initiatives and encouraging health players with grants and scientific prizes.

Hervé Le Lous has also presided for seven years the Pierre-Gilles de Gennes Foundation, dedicated to research. Today he actively invests himself to foster exchanges and partnerships between public and private scientific research.



Pierre Moustial

Since 2011, Pierre Moustial is Chief Executive Officer of URGO Group.

Graduate from HEC Business School where he taught, Pierre Moustial started his career in the banking sector, at BNP Paribas and at Dresdner Bank, as an advisor in mergers and acquisitions.

He joined the family-owned group founded by Hervé le Lous in 1995. Since then, he has held different positions within the Group’s companies.

From 1995 to 2003, he was Head of development of the Juva Santé Laboratories, and rapidly became a member of the executive committee of the group.

He contributed to the development of the Group’s consumer healthcare division, particularly with the acquisition and development of a company specialized in natural solutions (SUPER DIET Laboratories).
From 2003 to 2005, he was Chief Executive Officer of Fournier Laboratories.

In 2006, he then became Chief Executive Officer of Urgo Laboratories where he implemented a global growth strategy for the medical care market in wound healing, as well as for the selfcare market in pharmacies (Alvityl, Humex, Urgo,…) He also led the international development of the company through different acquisitions (in Asia, Latin America and Europe) and R&D to innovate in advanced wound care.

Today he is CEO of URGO Group and member of the Board.

He also teaches Finance at the URGO University, URGO Group’s corporate university.

In 2015, he was named by the French Government among the 40 personalities member of the executive committee of “Medecine of the Future”, a governmental initiative encouraging medical and digital innovation in the French Healthcare sector.

In 2016, Pierre Moustial was elected Chairman of MedTech in France, the Association of medical technology companies in France. The Association has to date over 40 medtech companies in the sector with many variations such as medical devices, e-health and telemedicine, optical technologies, surgical robotics, or medical imaging.



Ronan Blanchard
Chief Finance Officer and Head of Industry

Ronan Blanchard is URGO Group’s Chief Finance Officer and Head of Industry.

Ronan starts his careers within the Group in 2001 and works with Pierre Moustial in the Mergers-Acquisitions Department. In 2002, when Hervé Le Lous become President of the Fournier Laboratories, he assists him with the analysis of key projects and major negotiations. In 2006, Ronan become General Manager of SUPER DIET Laboratories. He contributes to making the natural healthcare company grow successfully , by developing its brands Herbesan, SUPER DIET, Oligocéan, Belloc, Ricqlès and OM3 in France and abroad.

In 2012, he become CFO of URGO International, the Group’s entity dedicated to international development. Based in Singapore, Ronan carries out the structuring of international activities and their financial management for Asia, Latin America and Eastern Europe.

In 2018, he is appointed Chief Financial Officer of URGO Group and Head of Industry. In this respect, he leads financial activities within the Group: accountability, controlling and IT teams. He also manages industrial activities (production and logistics).

Ronan graduated from the French business school HEC, where he taught corporate finance. He also teaches Negotiation and Decision Analysis to the Group’s managers at the URGO University, URGO Group’s corporate academy.



Briac Le Lous
President, Urgo Consumer Healthcare

Briac Le Lous is currently President of Urgo Consumer Healthcare, the healthcare and well-being division of URGO Group.

Briac started his career as Merger & Acquisition Director within the Group (2002-2010) and realized about fifteen acquisitions.

Holding different positions within the Group, he successively became General Manager of Danival (2004-2009); General Manager of Laboratoires Vie et Santé (2006-2010), and then General Manager of Laboratoires Juva Santé (2010-2015). Over these years, Briac carried out the development of URGO’s self-care and well-being division in France and abroad.

Briac is a member of the Board of Directors of URGO Group.

He is currently Vice-President of SYNADIET, the French syndicate for Food Supplements and a member of the Young President Organization (YPO). In 2017, he was named among the TOP 100 of tomorrow’s economic leaders (Institut Choiseul).

He holds a master degree from ENSAT and from AgroParisTech. Briac also graduated from HEC Entrepreneurs Business Master.



Tristan Le Lous
Board Member, in charge of Mergers & Acquisitions, Legal activities and the Group’s General Secretariat









Tristan Le Lous is currently Board Member in charge of mergers and acquisitions, legal activities and the Group’s general secretariat.

He started his career in 2005 in finance, within the company. In 2009, he added to his portfolio the M&A activities of the Group and successfully conducted several international acquisitions.

He then set up in 2017 the audit and compliance activities of the Group, which he supervises.

Tristan is member of the Board.

He holds a degree from the Ecole Normale Supérieure of Lyon in molecular genetics. He graduated from the agronomy engineering School of Paris (AgroParisTech) and from the business school ESCP Europe. He also holds a degree in Geographics from Nanterre University.


Guirec Le Lous
President, UrgoTech

Guirec Le Lous is General Manager of UrgoTech, the internal startup of URGO Group. UrgoTech develops innovative solutions to treat stress, insomnia, incontinence disorders and other chronic pathologies. At the crossroads between the last scientific neuroscience researches and reeducation techniques, UrgoTech is inventing tomorrow’s medicine.

After a first entrepreneurial experience, Guirec joined URGO Group in 2012. He contributed to URGO Group’s entering on new markets, each time with disruptive technologies : connected healthcare devices, hearing, aesthetic surgery.

He is a member of the Board.

Guirec graduated from the French engineering school Mines de Paris (MinesParisTech) with a specialization in Innovation management. Guirec also holds a degree from HEC Entrepreneurs.

Laurent Faugère
General Manager, URGO Medical

Laurent Faugère is currently General Manager of Urgo Medical, the medical care division of URGO Group.

He started as a Consultant at the Boston Consulting Group before becoming Business Unit Director within an international BioPharmaceutical company.

He graduated from the French Business School HEC.